Home  /  Resource Library  /  Real-world outcomes in Germany with standard of care axi-cel and tisa-cel in patients with large B cell lymphoma

Real-world outcomes in Germany with standard of care axi-cel and tisa-cel in patients with large B cell lymphoma

EBMT 2021: Study compared real world results with clinical trial results of CAR T axicabtagene ciloleucel and CAR T tisagenlecleucel for treatment of relapsed DLBCL.